Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 12024552 Ha binding agents

Patent 12024552 was granted and assigned to Visterra Inc. on July, 2024 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 3 Jul, 2024
"Created via: Patent importer"
Golden AI profile picture
Golden AI
created this topic on 3 Jul, 2024
Edits made to:
Infobox (+65 properties)
Article (+199 characters)
‌

 US Patent 12024552 Ha binding agents

Article

Patent abstract

This disclosure relates to novel peptide agents, e.g., antibodies and antigen-binding fragments thereof, that bind hemagglutinin protein of influenza viruses, and methods of their use.

Infobox
Is a
Patent
Patent
0
Patent Applicant
‌
Visterra Inc.
0
Current Assignee
‌
Visterra Inc.
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
120245520
Patent Inventor Names
Karthik Viswanathan0
Sasisekharan Raguram0
Vidya Subramanian0
Zachary Shriver0
Date of Patent
July 2, 2024
0
Patent Application Number
169938560
Date Filed
August 14, 2020
0
Patent Citations
‌
US Patent 7255859 Monoclonal antibodies against the epitope YPYDVPDYA, a process for their production and their use
0
‌
US Patent 7527800 Influenza hemagglutinin and neuraminidase variants
0
‌
US Patent 7537768 Influenza virus vaccine composition and methods of use
0
‌
US Patent 7566454 Influenza nucleic acids, polypeptides, and uses thereof
0
‌
US Patent 7566458 Influenza hemagglutinin and neuraminidase variants
0
‌
US Patent 7572620 H3 equine influenza A virus
0
‌
US Patent 7879326 Human neutralizing monoclonal antibodies to H5N1 influenza A virus
0
‌
US Patent 8124092 Antibodies against H5N1 strains of influenza A virus
0
‌
US Patent 8192927 Human bind molecules capable of neutralizing influenza virus h5n1 and uses thereof
0
‌
US Patent 8383121 Monoclonal antibodies specific to hemagglutinin and neuraminidase from influenza virus H5-subtype or N1-subtype and uses thereof
0
‌
US Patent 8444986 Monoclonal antibodies specific to hemagglutinin from influenza virus H5-subtype and uses thereof
0
‌
US Patent 8470327 Human binding molecules capable of neutralizing influenza virus H3N2 and uses thereof
0
‌
US Patent 8486406 Monoclonal antibodies as a medicament for the therapeutic and/or prophylactic treatment of swine-origin influenza A (H1N1) virus (S-OIV) infections
0
‌
US Patent 8540994 H5 subtype-specific binding proteins useful for H5 avian influenza diagnosis and surveillance
0
‌
US Patent 8540995 Monoclonal antibodies specific to the fusion peptide from hemagglutinin from influenza A viruses and uses thereof
0
‌
US Patent 8540996 Monoclonal antibodies specific to hemagglutinin and neuraminidase from influenza virus H5-subtype or N1-subtype and uses thereof
0
‌
US Patent 8574581 Monoclonal antibodies specific to hemagglutinin and neuraminidase from influenza virus H5-subtype or N1-subtype and uses thereof
0
‌
US Patent 8574830 Binding protein and epitope-blocking ELISA for the universal detection of H5-subtype influenza viruses
0
‌
US Patent 8603467 Monoclonal antibodies binding to avian influenza virus subtype H5 haemagglutinin and uses thereof
0
‌
US Patent 8613919 High concentration antibody and protein formulations
0
‌
US Patent 8637456 Engineered polypeptide agents for targeted broad spectrum influenza neutralization
0
‌
US Patent 8637644 H5 subtype-specific binding proteins useful for H5 avian influenza diagnosis and surveillance
0
‌
US Patent 8637645 H5 subtype-specific binding proteins useful for H5 avian influenza diagnosis and surveillance
0
‌
US Patent 8802110 Influenza treatment and/or characterization, human-adapted HA polypeptides; vaccines
0
‌
US Patent 8871207 Neutralizing anti-influenza A virus antibodies and uses thereof
0
‌
US Patent 8877200 HA binding agents
0
‌
US Patent 9096657 HA binding agents
0
‌
US Patent 9278998 Compositions and methods for diagnosing and/or treating influenza infection
0
‌
US Patent 9334309 Engineered polypeptide agents for targeted broad spectrum influenza neutralization
0
‌
US Patent 9572861 Engineered polypeptide agents for targeted broad spectrum influenza neutralization
0
‌
US Patent 9587010 Neutralizing anti-influenza A virus antibodies and uses thereof
0
‌
US Patent 9683030 Agents for influenza neutralization
0
‌
US Patent 9709567 Compositions and methods for diagnosing and/or treating influenza infection
0
‌
US Patent 9745352 Influenza treatment and/or characterization, human-adapted HA polypeptides; vaccines
0
‌
US Patent 9969794 HA binding agents
0
‌
US Patent 9982037 Agents for influenza neutralization
0
‌
US Patent 10226527 Hemagglutinin polypeptides, and reagents and methods relating thereto
0
‌
US Patent 11230593 Compositions and methods for treating and preventing influenza
0
‌
US Patent 10513553 Compositions and methods for treating and preventing influenza
0
‌
US Patent 10538578 Agents for influenza neutralization
0
‌
US Patent 10800835 HA binding agents
0
Patent Primary Examiner
‌
Bao Q Li
0
CPC Code
‌
G01N 33/56983
0
‌
C07K 2317/56
0
‌
C07K 2317/567
0
‌
C07K 2317/565
0
‌
C07K 16/1018
0
‌
A61K 39/395
0
‌
A61K 39/42
0
‌
A61K 39/145
0
‌
A61P 31/12
0
‌
A61P 31/16
0
‌
A61K 2039/505
0

Find more entities like US Patent 12024552 Ha binding agents

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo